Tasigna (Nilotinib)
150mg | 200mg
From $503.99
Tasigna (Nilotinib) is a targeted cancer therapy used to treat chronic myeloid leukemia (CML). It inhibits the abnormal protein responsible for uncontrolled cancer cell growth. Tasigna is taken on an empty stomach and requires regular monitoring due to potential side effects. It provides a more effective and selective treatment option for patients with Philadelphia chromosome-positive CML.
Select options
This product has multiple variants. The options may be chosen on the product page